Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 3:26 pm Sale | 13G | Oxford Immunotec Global PLC OXFD | Alyeska Investment Group L.P. | 0 0.000% | -1,341,518 (Position Closed) | View |
| 2022-02-14 10:46 am Sale | 13G | Oxford Immunotec Global PLC OXFD | Polar Capital Holdings Plc | 0 0.000% | -2,568,385 (Position Closed) | View |
| 2021-05-07 5:05 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | Grandeur Peak Global Advisors LLC | 570,836 2.230% | 570,000 (+68181.82%) | View |
| 2021-03-08 5:05 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | GLAZER CAPITAL LLC | 1,365,053 5.300% | 1,365,053 (New Position) | View |
| 2021-02-17 3:14 pm Sale | 13G | Oxford Immunotec Global PLC OXFD | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2021-02-17 09:33 am Sale | 13G | Oxford Immunotec Global PLC OXFD | Endurant Capital Management LP | 0 0.000% | -2,240,421 (Position Closed) | View |
| 2021-02-16 4:19 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | Consonance Capital Management LP | 6,058,505 11.000% | 6,058,505 (New Position) | View |
| 2021-02-16 2:39 pm Sale | 13G | Oxford Immunotec Global PLC OXFD | Consonance Capital Management LP | 0 0.000% | -2,363,724 (Position Closed) | View |
| 2021-02-16 11:21 am Purchase | 13G | Oxford Immunotec Global PLC OXFD | Alyeska Investment Group L.P. | 1,341,518 5.200% | 42,018 (+3.23%) | View |
| 2021-02-16 07:32 am Purchase | 13G | Oxford Immunotec Global PLC OXFD | Polar Capital Holdings Plc | 2,568,385 9.890% | 2,568,385 (New Position) | View |
| 2021-02-12 4:05 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | Senvest Management LLC | 1,470,593 5.660% | 144,739 (+10.92%) | View |
| 2021-02-12 3:41 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | Endurant Capital Management LP | 2,240,421 8.600% | 2,240,421 (New Position) | View |
| 2021-02-11 4:43 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | INTEGRATED CORE STRATEGIES (US) LLC | 1,326,384 5.200% | 96,555 (+7.85%) | View |
| 2021-02-10 8:35 pm Sale | 13G | Oxford Immunotec Global PLC OXFD | Grandeur Peak Global Advisors LLC | 836 2.230% | -1,323,307 (-99.94%) | View |
| 2021-02-10 4:35 pm Sale | 13G | Oxford Immunotec Global PLC OXFD | First Light Asset Management LLC | 95,400 0.370% | -4,950,730 (-98.11%) | View |
| 2021-02-03 4:27 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | INTEGRATED CORE STRATEGIES (US) LLC | 1,229,829 4.800% | 528,229 (+75.29%) | View |
| 2021-01-29 09:54 am Purchase | 13D | Oxford Immunotec Global PLC OXFD | Magnetar Financial LLC | 1,983,076 7.750% | 1,983,076 (New Position) | View |
| 2021-01-08 5:19 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | First Light Asset Management LLC | 5,046,130 19.440% | 320,139 (+6.77%) | View |
| 2020-06-10 1:32 pm Sale | 13G | Oxford Immunotec Global PLC OXFD | Invesco Ltd. IVZ | 18,166 0.100% | -2,073,119 (-99.13%) | View |
| 2020-05-27 4:41 pm Purchase | 13G | Oxford Immunotec Global PLC OXFD | First Light Asset Management LLC | 4,725,991 18.210% | 558,109 (+13.39%) | View |